CureusPub Date : 2025-06-23eCollection Date: 2025-06-01DOI: 10.7759/cureus.86591
Haruka Naiki, Shinji Sugita
{"title":"Acute Respiratory Failure and Metabolic Acidosis Due to Excessive Normal Saline Absorption During Hysteroscopic Myomectomy: A Case Report.","authors":"Haruka Naiki, Shinji Sugita","doi":"10.7759/cureus.86591","DOIUrl":"10.7759/cureus.86591","url":null,"abstract":"<p><p>Hysteroscopic myomectomy commonly employs fluid irrigation to maintain visualization of the uterine cavity, with normal saline often used as the distension medium due to its favorable safety profile. However, significant intravascular absorption of isotonic fluids can result in life-threatening complications. We report a case of acute respiratory failure and severe hyperchloremic metabolic acidosis caused by excessive absorption of normal saline during hysteroscopic myomectomy. The patient required mechanical ventilation and intensive care but recovered fully with timely and appropriate management. This case underscores the need for vigilant fluid balance monitoring during hysteroscopic procedures, even when isotonic irrigation solutions are used.</p>","PeriodicalId":93960,"journal":{"name":"Cureus","volume":"17 6","pages":"e86591"},"PeriodicalIF":1.0,"publicationDate":"2025-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12186287/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144487552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
CureusPub Date : 2025-06-23eCollection Date: 2025-06-01DOI: 10.7759/cureus.86609
Sathyaseelan Arumugam, Shaurya Aggarwal
{"title":"A Narrative Review of Selective Versus Routine Histopathological Examination of Gallbladders in Low-Risk Patients.","authors":"Sathyaseelan Arumugam, Shaurya Aggarwal","doi":"10.7759/cureus.86609","DOIUrl":"10.7759/cureus.86609","url":null,"abstract":"<p><p>Gallbladder diseases are common surgical conditions that often necessitate a cholecystectomy. Traditionally, gallbladder specimens are sent for routine histopathological examination to detect incidental gallbladder carcinoma (IGBC). However, the need for this in low-risk patients remains a subject of debate, particularly considering the low incidence of IGBC and the strain on pathology services. This narrative review aimed to compare selective versus routine histopathological examination of gallbladder specimens in low-risk patients undergoing cholecystectomy. This review complies with the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. A comprehensive search was conducted for studies between 2000 and 2022 across PubMed, Scopus, Embase, Web of Science, Cochrane Library, and ScienceDirect. Included studies involved patients with low preoperative suspicion of malignancy who were later diagnosed with gall bladder cancer via either routine or selective histopathological examination. Sixteen studies met the inclusion criteria. Studies supporting selective histopathology reported that all cases of IGBC were suspected either preoperatively on imaging or intraoperatively based on macroscopic features. In contrast, studies advocating routine histology identified significant numbers of IGBC in patients with no intraoperative suspicion, including some with advanced-stage disease. These findings suggest that while selective examination may be safe in low-incidence regions with experienced surgical assessment, routine histology remains a more sensitive method in other areas. Selective histopathological examination of gall bladder specimens may be considered in carefully selected low-risk patients, provided a thorough intraoperative evaluation is performed. However, routine examinations remain important in regions with higher disease prevalence.</p>","PeriodicalId":93960,"journal":{"name":"Cureus","volume":"17 6","pages":"e86609"},"PeriodicalIF":1.0,"publicationDate":"2025-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12184954/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144478264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
CureusPub Date : 2025-06-23eCollection Date: 2025-06-01DOI: 10.7759/cureus.86594
Indrawarman Soerohardjo, Ahmad Zulfan Hendri, Ahmad Shafwan Natsir, Narpati Wesa Pikatan, Toni Febriyanto
{"title":"Effective Management of Transuretero-Ureterocutaneostomy (TUUC)-Related Stenosis Using a Combined Antegrade and Retrograde Approach With Holmium Laser Endoureterotomy: A Case Report.","authors":"Indrawarman Soerohardjo, Ahmad Zulfan Hendri, Ahmad Shafwan Natsir, Narpati Wesa Pikatan, Toni Febriyanto","doi":"10.7759/cureus.86594","DOIUrl":"10.7759/cureus.86594","url":null,"abstract":"<p><p>Bladder cancer (BC) is the seventh most common cancer globally, with significant morbidity and mortality. Radical cystectomy is the primary treatment for muscle-invasive bladder cancer (MIBC), often followed by urinary diversion techniques such as transuretero-ureterocutaneostomy (TUUC). While TUUC can be an effective alternative to urinary diversions, it is associated with complications, including anastomotic stenosis. A 60-year-old male with BC underwent radical cystectomy followed by TUUC. Postoperatively, the patient developed anastomotic stenosis, initially managed with stent placement. However, left flank pain and oliguria persisted, and imaging revealed grade 2 left hydronephrosis and elevated creatinine levels. Two operators performed the procedure, using antegrade access percutaneously as a guiding approach and retrograde access through the TUUC orifice to perform the holmium laser endoureterotomy. The holmium laser endoureterotomy was successfully performed using a dual-access technique, combining both antegrade and retrograde approaches to enhance precision and minimize tissue damage. Post-procedure, the patient experienced significant relief from symptoms, and renal function improved markedly, with decreased creatinine levels. This case underscores the effectiveness of a combined approach of holmium laser endoureterotomy in managing TUUC-related stenosis. It offers a minimally invasive solution for maintaining patency and enhancing patient outcomes after complex urinary diversion procedures.</p>","PeriodicalId":93960,"journal":{"name":"Cureus","volume":"17 6","pages":"e86594"},"PeriodicalIF":1.0,"publicationDate":"2025-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12184731/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144478295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
CureusPub Date : 2025-06-23eCollection Date: 2025-06-01DOI: 10.7759/cureus.86625
Mohammed As'ad
{"title":"Axial Skeletal Assessment in Osteoporosis Using Radiofrequency Echographic Multi-spectrometry: Diagnostic Performance, Clinical Utility, and Future Directions.","authors":"Mohammed As'ad","doi":"10.7759/cureus.86625","DOIUrl":"10.7759/cureus.86625","url":null,"abstract":"<p><p>Osteoporosis, a prevalent skeletal disorder, necessitates accurate and accessible diagnostic tools for effective disease management and fracture prevention. While dual-energy X-ray absorptiometry (DXA) remains the clinical standard for bone mineral density (BMD) assessment, its limitations, including ionizing radiation exposure and susceptibility to artifacts, underscore the need for alternative technologies. Ultrasound-based methods have emerged as promising radiation-free alternatives, with radiofrequency echographic multi-spectrometry (REMS) representing a significant advancement in axial skeleton assessment, specifically at the lumbar spine and proximal femur. REMS analyzes unfiltered radiofrequency ultrasound signals, providing not only BMD estimates but also a novel fragility score (FS), which reflects bone quality and microarchitectural integrity. This review critically evaluates the underlying principles, diagnostic performance, and clinical applications of REMS. It compares REMS with DXA, quantitative computed tomography (QCT), and trabecular bone score (TBS), highlighting REMS's potential advantages in artifact-prone scenarios and specific populations, including children and patients with secondary osteoporosis. The clinical utility of REMS in fracture risk prediction and therapy monitoring is explored alongside its operational precision, cost-effectiveness, and portability. In addition, the integration of artificial intelligence (AI) within REMS software has enhanced its capacity for artifact exclusion and automated spectral interpretation, improving usability and reproducibility. Current limitations, such as the need for broader validation and guideline inclusion, are identified, and future research directions are proposed. These include multicenter validation studies, development of pediatric and secondary osteoporosis reference models, and deeper evaluation of AI-driven enhancements. REMS offers a compelling, non-ionizing alternative for axial bone health assessment and may significantly advance the diagnostic landscape for osteoporosis care.</p>","PeriodicalId":93960,"journal":{"name":"Cureus","volume":"17 6","pages":"e86625"},"PeriodicalIF":1.0,"publicationDate":"2025-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12185786/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144487553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
CureusPub Date : 2025-06-22eCollection Date: 2025-06-01DOI: 10.7759/cureus.86546
S Khallikane, Youssef Qamouss, Monsef Elabdi, Abdelmajid Bouzerda, Ali Khatouri, Mohamed Zyani, Rachid Seddiki
{"title":"Angiotensin II in Catecholamine-Refractory Shock: A Systematic Review and Exploratory Analysis of the Angiotensin II for the Treatment of High-Output Shock (ATHOS-3) Trial.","authors":"S Khallikane, Youssef Qamouss, Monsef Elabdi, Abdelmajid Bouzerda, Ali Khatouri, Mohamed Zyani, Rachid Seddiki","doi":"10.7759/cureus.86546","DOIUrl":"10.7759/cureus.86546","url":null,"abstract":"<p><p>Vasodilatory shock that does not respond to high-dose catecholamine vasopressors remains a life-threatening condition and is characterized by severe hypotension and high mortality. Angiotensin II, a non-catecholamine vasopressor that activates angiotensin type 1 receptors, has emerged as a potential therapeutic agent for restoring vascular tone in this setting. This systematic review aimed to evaluate the efficacy, safety, and hemodynamic effects of intravenous angiotensin II in adult patients with vasodilatory shock unresponsive to catecholamines, with a focus on data from the Angiotensin II for the Treatment of High-Output Shock (ATHOS-3) randomized trial and related studies. Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines, a systematic search was performed to identify randomized controlled trials and protocol-based investigations involving angiotensin II administration in adult patients with catecholamine-refractory vasodilatory shock. Eligible studies included the ATHOS-3 randomized trial, a renal-focused post hoc analysis, and the DARK-Sepsis protocol. Extracted outcomes included the proportion of patients achieving target mean arterial pressure, changes in catecholamine dose requirements, incidence of renal replacement therapy, and adverse event profiles. Risk of bias was assessed using the Cochrane Risk of Bias 2.0 tool. Three studies involving a total of 321 patients were included. In the ATHOS-3 trial, angiotensin II significantly increased mean arterial pressure within 30 minutes. The proportion of patients achieving the target pressure threshold was 69.9% in the angiotensin II group versus 23.4% in the placebo group (P < 0.001). Angiotensin II administration was associated with a reduction in concurrent catecholamine use and a lower rate of renal replacement therapy initiation (19.0% versus 32.4%; P = 0.015). The overall incidence of adverse events, including thromboembolic and ischemic complications, did not differ significantly between groups. Exploratory findings indicated a greater therapeutic response in patients with elevated baseline plasma renin levels. All studies included were rated as low risk of bias. Angiotensin II appears to be a safe and effective adjunct to conventional vasopressor therapy in catecholamine-refractory vasodilatory shock, offering rapid hemodynamic improvement and potential organ protection. The observed reduction in renal replacement therapy initiation and the enhanced response in renin-elevated subgroups warrant further investigation in biomarker-guided clinical trials.</p>","PeriodicalId":93960,"journal":{"name":"Cureus","volume":"17 6","pages":"e86546"},"PeriodicalIF":1.0,"publicationDate":"2025-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12182914/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144478288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
CureusPub Date : 2025-06-22eCollection Date: 2025-06-01DOI: 10.7759/cureus.86525
Bugude Shiva Shankar
{"title":"Global Youth Tobacco Survey (2001-2022) in Saudi Arabia: An Analysis of Forecasting and Insights Pertaining to Dental Public Health and Tobacco Cessation Counseling.","authors":"Bugude Shiva Shankar","doi":"10.7759/cureus.86525","DOIUrl":"10.7759/cureus.86525","url":null,"abstract":"<p><strong>Background: </strong> Tobacco use among youth is a critical public health concern, particularly in Saudi Arabia, where a significant youth demographic and evolving tobacco control policies shape usage patterns. The Global Youth Tobacco Survey (GYTS) provides standardized data to monitor these trends, offering insights for dental public health and tobacco cessation counseling. This study analyzes GYTS data from 2001 to 2022 to evaluate trends in youth tobacco use, their association with tobacco control policy implementation, and implications for oral health interventions.</p><p><strong>Materials and methods: </strong> Data from the GYTS conducted in Saudi Arabia (2001, 2007, 2010, and 2022) among youth aged 13-15 years (n = 1,830-4,526) were analyzed. Key indicators included current cigarette smoking, environmental tobacco smoke exposure, cessation attempts, and knowledge/attitudes toward smoking. Descriptive statistics, percent change calculations, linear and joinpoint regression analyses, and gender-specific comparisons assessed trends and policy impacts. Prediction models forecast the prevalence to 2030. Statistical analyses were performed using Python (version 3.10; Python Software Foundation, Wilmington, DE) and the Joinpoint Regression Program (version 4.9.1.0; National Cancer Institute, Bethesda, MD).</p><p><strong>Results: </strong> Current cigarette smoking increased from 4.7% (2001) to 8.9% (2010) before declining to 2.9% (2022), a 38.3% relative decrease. Joinpoint analysis identified a significant trend reversal after 2010, coinciding with comprehensive MPOWER policy implementation (p < 0.001). Boys exhibited higher smoking prevalence than girls, but the gender gap narrowed from 4.0 to 1.3 percentage points (2001-2022). Environmental tobacco smoke exposure and living with smokers decreased by 28.8% and 33.0%, respectively. Cessation indicators showed declines in desire (74.0%-64.9%) and attempts to quit (69.3%-58.7%). Support for smoking bans rose by 14.6%. Predictions suggest smoking prevalence may approach 1.0%-2.0% by 2030 if trends persist.</p><p><strong>Conclusion: </strong> Comprehensive tobacco control policies after 2010 significantly reduced youth tobacco use in Saudi Arabia, with notable declines in smoking prevalence and environmental exposure. However, declining cessation indicators highlight the need for targeted interventions. Dental professionals can leverage these trends to integrate cessation counseling into routine care, enhancing oral health outcomes. Sustained policy enforcement and gender-sensitive strategies are crucial to further reduce youth tobacco use by 2030.</p>","PeriodicalId":93960,"journal":{"name":"Cureus","volume":"17 6","pages":"e86525"},"PeriodicalIF":1.0,"publicationDate":"2025-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12185262/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144487555","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
CureusPub Date : 2025-06-22eCollection Date: 2025-06-01DOI: 10.7759/cureus.86515
Omer Kheir, Mohammed Ghamdi, Sheikha Dossary, Anwar B Alotaibi, Elrasheed M Elsabani, Hanin Fahad, Mona Alfaifi
{"title":"Evaluating the Performance of Four Risk Assessment Scores in Nonvariceal Upper Gastrointestinal Bleeding.","authors":"Omer Kheir, Mohammed Ghamdi, Sheikha Dossary, Anwar B Alotaibi, Elrasheed M Elsabani, Hanin Fahad, Mona Alfaifi","doi":"10.7759/cureus.86515","DOIUrl":"https://doi.org/10.7759/cureus.86515","url":null,"abstract":"<p><strong>Introduction: </strong> Nonvariceal upper gastrointestinal bleeding (NVUGIB) continues to remain a life-threatening medical emergency, resulting in significant morbidity and mortality. Several scoring systems have been developed to predict outcomes, but the best risk stratification tool for emergency situations remains uncertain. This study examines four existing scoring systems: the blood urea nitrogen-to-serum albumin ratio (BAR), the international normalized ratio-to-albumin ratio (PTAR), the lactate-to-albumin ratio (LTA), and the National Early Warning Score (NEWS).</p><p><strong>Methods: </strong> This retrospective, hospital-based study was conducted at the Johns Hopkins Aramco Healthcare (JHAH) facility in eastern Saudi Arabia from January 2020 to September 2023. Eligible participants were non-trauma UGIB patients aged 18 years or older. Cancer patients were excluded. Patient characteristics, vital signs, test results, comorbidities, disposition, and survival status at discharge were among the information collected from medical records. The four score systems were calculated and compared based on their predictive performance.</p><p><strong>Result: </strong>NEWS demonstrated the highest overall predictive performance, particularly for hospital admission (AUC 84%) and 90-day mortality (AUC 77.2%). Both NEWS and BAR were equally effective in predicting blood transfusion (AUC 71.7%). LTA showed the highest sensitivity for mortality prediction (75%), while PTAR provided moderate predictive value across all outcomes.</p><p><strong>Conclusion: </strong>Among the four scoring systems evaluated, NEWS consistently outperformed others in predicting key clinical outcomes in NVUGIB, making it a reliable tool for initial risk stratification. BAR is also valuable for assessing transfusion needs, while LTA and PTAR may serve complementary roles depending on the clinical context.</p>","PeriodicalId":93960,"journal":{"name":"Cureus","volume":"17 6","pages":"e86515"},"PeriodicalIF":1.0,"publicationDate":"2025-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12221101/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144556170","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
CureusPub Date : 2025-06-22eCollection Date: 2025-06-01DOI: 10.7759/cureus.86527
Abdulrahman Alangari
{"title":"To IV or Not to IV: The Science Behind Intravenous Vitamin Therapy.","authors":"Abdulrahman Alangari","doi":"10.7759/cureus.86527","DOIUrl":"10.7759/cureus.86527","url":null,"abstract":"<p><p>Intravenous (IV) vitamin therapy has become an increasingly popular method for delivering essential micronutrients directly into the bloodstream, bypassing the gastrointestinal tract. This method offers enhanced bioavailability, higher therapeutic dosages, and targeted nutrient replenishment, making it particularly effective for individuals with malabsorption issues and chronic illnesses and those seeking optimal health benefits. In contrast, oral supplementation remains a convenient and practical option for routine vitamin and mineral intake. This article provides an overview of the physiological advantages and disadvantages of IV vitamin therapy, its clinical applications, and the scientific evidence supporting its efficacy.</p>","PeriodicalId":93960,"journal":{"name":"Cureus","volume":"17 6","pages":"e86527"},"PeriodicalIF":1.0,"publicationDate":"2025-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12182718/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144478301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Mitral Valve Replacement via Minithoracotomy Versus Conventional Median Sternotomy in Rheumatic Mitral Valve Disease: A Multicenter Retrospective Study.","authors":"Hicham Kbiri, Rachid Seddiki, Abdellatif Chlouchi, Najib Bouhabba, Amine Meskine, Mourad Ababou, Youssef Qamouss, S Khallkane","doi":"10.7759/cureus.86482","DOIUrl":"10.7759/cureus.86482","url":null,"abstract":"<p><p>Background and objectives This study aimed to compare surgical outcomes, early postoperative complications, and midterm recovery in patients with severe rheumatic mitral insufficiency undergoing either minimally invasive cardiac surgery (MICS) or mitral valve replacement via conventional median sternotomy (CMS). While CMS remains the standard approach, MICS has emerged as a less invasive option with potential benefits. However, comparative data in resource-limited settings remain scarce. Methods This multicenter retrospective study included 55 adults with severe rheumatic mitral Insufficiency (RMI) who underwent elective mechanical mitral valve replacement between 2020 and 2024 in Morocco. Patients were divided into two groups: 27 received minimally invasive surgery (MICS) via minithoracotomy, and 28 underwent conventional sternotomy (CMS). The primary endpoint was 30-day all-cause mortality. Secondary outcomes included operative times, postoperative complications, intensive care unit (ICU)/hospital stay duration, 12-month functional recovery, valve performance, and event-free survival based on Kaplan-Meier analysis. Results Fifty-five patients underwent mechanical mitral valve replacement: 27 via minimally invasive cardiac surgery (MICS) and 28 via conventional median sternotomy (CMS). The 30-day mortality was similar between groups (3.7% vs 3.6%; p = .99). Compared with CMS, MICS was associated with significantly shorter cardiopulmonary bypass (68.3 vs 87.5 minutes; p < .001) and aortic cross-clamp times (54.7 vs 77.1 minutes; p < .001), reduced postoperative pneumonia (0% vs 10.7%; p = .03), and fewer arrhythmias (7.4% vs 39.3%; p = .04). Hospital stay was shorter in the MICS group (6.2 vs 7.3 days; p = .04), with similar ICU duration. At 12 months, both groups showed preserved left ventricular ejection fraction (60.1% vs 58.2%; p = .22) and comparable event-free survival (>90%), without significant differences in valve-related complications. Conclusions In this multicenter retrospective study, minimally invasive cardiac surgery (MICS) for severe rheumatic mitral insufficiency was associated with fewer early complications, shorter operative and recovery times, and equivalent 12-month outcomes compared with conventional median sternotomy. These findings support MICS as a safe and effective alternative in appropriately selected patients when performed in experienced surgical centers.</p>","PeriodicalId":93960,"journal":{"name":"Cureus","volume":"17 6","pages":"e86482"},"PeriodicalIF":1.0,"publicationDate":"2025-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12181818/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144478299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
CureusPub Date : 2025-06-21eCollection Date: 2025-06-01DOI: 10.7759/cureus.86496
Ky D Nguyen, Anh Tn Khuc, Vu A Tran, Hieu S Nguyen, Phong H Nguyen, Anh Th Nguyen
{"title":"Antepartum Serum Lactate Dehydrogenase and Adverse Obstetric Outcomes in Preeclampsia: A Systematic Review of Prognostic Evidence From Low- and Middle-Income Countries.","authors":"Ky D Nguyen, Anh Tn Khuc, Vu A Tran, Hieu S Nguyen, Phong H Nguyen, Anh Th Nguyen","doi":"10.7759/cureus.86496","DOIUrl":"10.7759/cureus.86496","url":null,"abstract":"<p><p>This systematic review evaluated the association between antepartum serum lactate dehydrogenase (LDH) levels and adverse maternal and perinatal outcomes in preeclamptic pregnancies in low- and middle-income countries (LMICs). A comprehensive search of PubMed, Embase, and Scopus identified 19 observational studies published between 2000 and 2025, comprising 5,039 pregnant women, including 3,782 preeclampsia diagnoses. Most studies were conducted in South Asia and the Middle East. Although LDH thresholds varied, a consistent trend was observed: higher LDH levels were associated with increased risk of maternal complications such as HELLP syndrome, disseminated intravascular coagulation, acute renal failure, and ICU admission. Perinatal complications, including stillbirth, intrauterine growth restriction, low Apgar scores, and neonatal intensive care unit (NICU) admission, were also more common at LDH levels >800 IU/L. For example, stillbirth occurred in up to 77.7% of cases in the highest LDH group compared to <3% in the lowest. Due to heterogeneity in cut-offs and outcome definitions, meta-analysis was not performed. Overall, elevated antepartum serum LDH appears to be a strong prognostic marker for severe outcomes in preeclamptic pregnancies and may aid clinical triage in LMICs. Further prospective studies are needed to establish standardized thresholds and validate their predictive utility.</p>","PeriodicalId":93960,"journal":{"name":"Cureus","volume":"17 6","pages":"e86496"},"PeriodicalIF":1.0,"publicationDate":"2025-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12182434/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144478290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}